Mogamulizumab‐associated rash – Case series and review of the literature
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024
DOI: 10.1111/ddg.15432 ↗Kurz gefasst
Fallbericht in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024. Verfasst von Inga Hansen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Skin Neoplasms, Exanthema. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Mogamulizumab, a monoclonal antibody directed against CC chemokine receptor 4, is approved as a second‐line treatment of mycosis fungoides and Sézary syndrome. One of the most common side effects is mogamulizumab‐associated rash (MAR), which can present in a variety of clinical and histological types. Clinically, it can be difficult to differentiate between MAR and progression of the underlying disease, so histological examination is crucial for clinicopathological correlation. Current data analyses suggest that MAR is more common in patients with Sézary syndrome and is associated with a significantly better response to treatment, making the distinction from disease progression particularly important. The management of MAR depends on its severity, and therapy may need to be paused. This article presents three cases from our clinic and reviews the current literature on MAR. It emphasizes the importance of understanding MAR in the management of patients with cutaneous lymphomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Finn Abeck
Zitieren
APA
Hansen, I., Abeck, F., Menz, A., Schneider, S. W., & Booken, N. (2024). Mogamulizumab‐associated rash – Case series and review of the literature. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15432
Vancouver
Hansen I, Abeck F, Menz A, Schneider SW, Booken N. Mogamulizumab‐associated rash – Case series and review of the literature. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024. doi:10.1111/ddg.15432
BibTeX
@article{Hansen2024,
author = {Hansen, Inga and Abeck, Finn and Menz, Anne and Schneider, Stefan W and Booken, Nina},
title = {Mogamulizumab‐associated rash – Case series and review of the literature},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2024},
doi = {10.1111/ddg.15432}
}
EUVIMED